Ovidrel is intended for SC administration.
Treatment with Ovidrel should be performed under the supervision of a physician experienced in the treatment of fertility problems.
Women Undergoing Superovulation Prior to Assisted Reproductive Techniques eg, in vitro Fertilisation (IVF): 1 pre-filled syringe is administered 24-48 hrs after the last administration of an FSH or hMG preparation ie, when optimal stimulation of follicular growth is achieved.
Anovulatory or Oligo-Ovulatory Women: 1 pre-filled syringe is administered 24-48 hrs after optimal stimulation of follicular growth is achieved. The patient is recommended to have coitus on the day of, and the day after, Ovidrel injection.